TY  - BOOK
AU  - Singh,Rajesh Kumar
TI  - Key Heterocyclic Cores for Smart Anticancer Drug-Design Part II
SN  - 9815040049
AV  - RC271.C5 
U1  - 616.994061 23/eng/20240827
PY  - 2022///
CY  - Sharjah
PB  - Bentham Science Publishers
KW  - Cancer
KW  - Chemotherapy
KW  - Treatment
KW  - Drugs
KW  - Design
KW  - Cyclic compounds
KW  - Drug Design
KW  - Traitement
KW  - Chimioth�erapie
KW  - M�edicaments
KW  - Conception
KW  - Compos�es cycliques
N1  - Description based upon print version of record
N2  - This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3390582
ER  -